What purplkat said. Also, the cancer drug IS being researched in humans.
http://www.depmed.ualberta.ca/dca/ "The University of Alberta’s DCA Research Team is set to launch clinical trials on humans in the spring of 2007 pending government approval. Knowing that thousands of cancer patients die weekly while waiting for a cure, Dr. Michelakis and his team are working at accelerated speed, condensing research that usually takes years into months. Fundraisers at the University of Alberta are determined to raise the money to allow this next phase of research to begin. Once Health Canada grants formal approval, the University of Alberta’s Research Team will begin testing DCA on patients living with cancer. Results with regards to the safety and efficacy of treatment should be known late this year."
The articles talking about worries about it not being researched were referring to the fact that because no pharmaceutical company owns the patent on it, no company would be willing to privately fund it, such that individual donations, cancer society donations, and government grants will have to make it happen entirely on their own. Normally drug development is funded by pharmaceuticals hoping to make a buck off a patent.
![[personal profile]](https://www.dreamwidth.org/img/silk/identity/user.png){kind=small}
![[livejournal.com profile]](https://www.dreamwidth.org/img/external/lj-userinfo.gif){kind=small}
![[identity profile]](https://www.dreamwidth.org/img/silk/identity/openid.png){kind=small}
(no subject)
Date: 2007-05-10 03:57 pm (UTC)http://www.depmed.ualberta.ca/dca/
"The University of Alberta’s DCA Research Team is set to launch clinical trials on humans in the spring of 2007 pending government approval. Knowing that thousands of cancer patients die weekly while waiting for a cure, Dr. Michelakis and his team are working at accelerated speed, condensing research that usually takes years into months. Fundraisers at the University of Alberta are determined to raise the money to allow this next phase of research to begin. Once Health Canada grants formal approval, the University of Alberta’s Research Team will begin testing DCA on patients living with cancer. Results with regards to the safety and efficacy of treatment should be known late this year."
The articles talking about worries about it not being researched were referring to the fact that because no pharmaceutical company owns the patent on it, no company would be willing to privately fund it, such that individual donations, cancer society donations, and government grants will have to make it happen entirely on their own. Normally drug development is funded by pharmaceuticals hoping to make a buck off a patent.